10x Genomics ‘overjoyed’ to win UPC injunction

The decision is the first UPC injunction in open court, and could have far-reaching consequences for NanoString in the EU.

Pfizer must hand over vaccine knowledge

The big pharma firm must “specifically describe” its awareness of Moderna's work in the mRNA COVID-19 vaccine sphere before the end of the month.

Femtech: from taboo to multibillion-dollar industry

Technology is continuing to transform women’s healthcare and female inventors are driving the change—but more needs to be done to ensure they secure IP rights.

UK universities prove resilience during Horizon hiatus

Although UK research universities were going strong after Horizon funding was pulled, it was not a sustainable path had the scheme not been reinstated, finds Sarah Speight.

Regimen patents in Japan: LCM failures and successes

Regimen patents in Japan: LCM failures and successes

Examining a series of case studies, Takanori Abe of Abe & Partners provides an overview of lifecycle management failures and successes in regimen patents.

More features

Latest news

NanoString to appeal 10x’s UPC injunction ‘immediately’

21-09-2023

The spatial biology firm will appeal the Unified Patent Court’s preliminary injunction | NanoString accuses 10x of ‘misusing non-final court rulings…to eliminate competition in the spatial transcriptomics market’.

Roche unit wins Fed Circ clash over blood clot treatment

21-09-2023

10x Genomics 'overjoyed' to win UPC preliminary injunction

19-09-2023

Pfizer must hand over COVID-19 vaccine knowledge

19-09-2023

US Court of Appeals sides with Apple in Masimo dispute

14-09-2023

Bausch Ireland fends off challenge to its cancer patent

12-09-2023

More news

Regions

Sectors

LSIPR